AQR Capital Management
PGEN icon

AQR Capital Management’s Precigen PGEN Stock Holding History

AQR Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$830K Sell
145,600
-39,394
-21% -$170K ﹤0.01% 3109
2026
Q1 		$716K Sell
184,994
-1,406
-0.8% -$5.77K ﹤0.01% 2952
2025
Q4 		$779K Buy
186,400
+79,939
+75% +$309K ﹤0.01% 2689
2025
Q3 		$350K Sell
106,461
-11,205
-10% -$31.6K ﹤0.01% 3006
2025
Q2 		$167K Buy
117,666
+54,487
+86% +$77.4K ﹤0.01% 3095
2025
Q1 		$94.1K Buy
63,179
+43,245
+217% +$68.1K ﹤0.01% 3023
2024
Q4 		$22.3K Buy
19,934
+4,041
+25% +$3.45K ﹤0.01% 2842
2024
Q3 		$15.1K Sell
15,893
-34,109
-68% -$43K ﹤0.01% 2743
2024
Q2 		$79K Buy
50,002
+18,097
+57% +$26.3K ﹤0.01% 2514
2024
Q1 		$46.3K Buy
+31,905
New +$45.8K ﹤0.01% 2378
2023
Q4 		– Sell
-86,614
Closed -$123K – 2418
2023
Q3 		$123K Sell
86,614
-56,222
-39% -$79.7K ﹤0.01% 2207
2023
Q2 		$164K Sell
142,836
-212,629
-60% -$251K ﹤0.01% 2103
2023
Q1 		$377K Sell
355,465
-191,431
-35% -$276K ﹤0.01% 1869
2022
Q4 		$831K Sell
546,896
-72,490
-12% -$125K ﹤0.01% 1619
2022
Q3 		$1.31M Buy
619,386
+130,585
+27% +$275K ﹤0.01% 1399
2022
Q2 		$655K Buy
488,801
+219,599
+82% +$326K ﹤0.01% 1583
2022
Q1 		$568K Buy
269,202
+52,028
+24% +$127K ﹤0.01% 1773
2021
Q4 		$806K Buy
217,174
+143,992
+197% +$620K ﹤0.01% 1655
2021
Q3 		$365K Buy
73,182
+22,021
+43% +$127K ﹤0.01% 1979
2021
Q2 		$334K Sell
51,161
-35,213
-41% -$246K ﹤0.01% 2020
2021
Q1 		$595K Buy
+86,374
New +$730K ﹤0.01% 1772
2017
Q1 		– Sell
-166,126
Closed -$4M – 2237
2016
Q4 		$4M Sell
166,126
-957,700
-85% -$26.7M 0.01% 1125
2016
Q3 		$31.2M Sell
1,123,826
-279,903
-20% -$7.4M 0.05% 475
2016
Q2 		$34.2M Buy
1,403,729
+948,054
+208% +$26.9M 0.06% 425
2016
Q1 		$15.3M Sell
455,675
-343,837
-43% -$10.8M 0.03% 600
2015
Q4 		$23.9M Buy
799,512
+585,330
+273% +$19.7M 0.04% 505
2015
Q3 		$6.75M Buy
214,182
+157,155
+276% +$7.67M 0.01% 713
2015
Q2 		$2.76M Buy
57,027
+51,377
+909% +$2.17M 0.01% 1045
2015
Q1 		$245K Buy
+5,650
New +$203K ﹤0.01% 1951

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AQR Capital Management's PGEN Position: Q2 2026 in Review

AQR Capital Management reduced its Precigen (PGEN) stake by 21% in Q2 2026, selling an estimated $170K and leaving 145,600 shares worth $830K. The position accounts for ﹤0.01% of the portfolio, ranked #3109.

AQR Capital Management first reported a position in PGEN in Q1 2015 and has held it in 29 quarters since. The position peaked at $34.2M in Q2 2016. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • AQR Capital Management held 145,600 shares of Precigen worth $830K as of Q2 2026.
  • AQR Capital Management sold 39,394 Precigen shares in Q2 2026, an estimated $170K.
  • Precigen made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #3109 holding.
  • AQR Capital Management first reported a position in Precigen in Q1 2015 and has held it in 29 quarters since.
  • AQR Capital Management's Precigen position peaked at $34.2M in Q2 2016.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.